Amanda Uber
No Rating Available
(Learn About Our Rating System)

Amanda Uber, DO

Languages spoken: English

Clinical Locations

Eccles Primary Children's Outpatient Services

Salt Lake City
801-213-3599

  • Dr. Uber received her medical degree from Arizona College of Osteopathic Medicine, Midwestern University. She completed her Pediatric residency at Stanford University/Lucile Packard Children’s Hospital-Stanford Children’s Health. She remained at Stanford and serving as Chief Resident for the Pediatric Residency Program with roles as both an inpatient hospitalist and a general outpatient pediatrician. She then completed her Pediatric Nephrology fellowship at Stanford University/Lucile Packard Children’s Hospital-Stanford Children’s Health before joining faculty at the University of Nebraska Medical Center and Children’s Hospital in Nebraska in 2021.

    She is currently an Assistant Professor of Pediatrics at the University of Utah, in the Division of Pediatric Nephrology and Hypertension at Primary Children’s Medical Center. Dr Uber’s clinical interests include acute kidney injury, chronic kidney disease, dialysis and nutrition. She enjoys caring for complex patients with end-stage kidney disease on dialysis and those undergoing kidney transplantation. Dr Uber’s research interests include quality improvement, cardiac patients with kidney disease and nephrotoxin induced kidney injury.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Nephrology)

  • Dr. Uber received her medical degree from Arizona College of Osteopathic Medicine, Midwestern University. She completed her Pediatric residency at Stanford University/Lucile Packard Children’s Hospital-Stanford Children’s Health. She remained at Stanford and serving as Chief Resident for the Pediatric Residency Program with roles as both an inpatient hospitalist and a general outpatient pediatrician. She then completed her Pediatric Nephrology fellowship at Stanford University/Lucile Packard Children’s Hospital-Stanford Children’s Health before joining faculty at the University of Nebraska Medical Center and Children’s Hospital in Nebraska in 2021.

    She is currently an Assistant Professor of Pediatrics at the University of Utah, in the Division of Pediatric Nephrology and Hypertension at Primary Children’s Medical Center. Dr Uber’s clinical interests include acute kidney injury, chronic kidney disease, dialysis and nutrition. She enjoys caring for complex patients with end-stage kidney disease on dialysis and those undergoing kidney transplantation. Dr Uber’s research interests include quality improvement, cardiac patients with kidney disease and nephrotoxin induced kidney injury.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Nephrology)

    Education history

    Fellowship Pediatric Nephrology - Stanford University School of Medicine Chief Fellow
    Pediatric Nephrology - Stanford University School of Medicine Fellow
    Chief Resident Pediatrics - Stanford University School of Medicine Chief Resident
    Categorical Pediatrics - Stanford University School of Medicine Resident
    Professional Medical Osteopathic Medicine - Midwestern University Arizona College of Osteopathic Medicine D.O.
    Major: Molecular Biology; Minors: Chemistry & Religious Studies - University of Denver B.S.

    Selected Publications

    Journal Article

    1. Uber AM, Han J, Grimm P, Montez-Rath ME, Chaudhuri A (2024). Defining systolic blood pressure normative values in hospitalized pediatric patients: a single center experience. Pediatr Res, 95(7), 1860-1867. (Read full article)
    2. Gist KM, Menon S, Anton-Martin P, Bigelow AM, Cortina G, Deep A, De la Mata-Navazo S, Gelbart B, Gorga S, Guzzo I, Mah KE, Ollberding NJ, Shin HS, Thadani S, Uber A, Zang H, Zappitelli M, Selewski DT, WE-ROCK Investigators (2024). Time to Continuous Renal Replacement Therapy Initiation and 90-Day Major Adverse Kidney Events in Children and Young Adults. JAMA Netw Open, 7(1), e2349871. (Read full article)
    3. Miller P, Xiao AY, Kung VL, Sibley RK, Higgins JP, Kambham N, Charu V, Lenihan C, Uber A, Talley EM, Arora N, Walavalkar V, Laszik ZG, Nast CC, Troxell ML (2020). Progression of proliferative glomerulonephritis with monoclonal IgG deposits in pediatric patients. Pediatr Nephrol, 36(4), 927-937. (Read full article)
    4. Uber AM, Montez-Rath ME, Kwiatkowski DM, Krawczeski CD, Sutherland SM (2018). Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery. Pediatr Nephrol, 33(11), 2193-2199. (Read full article)
    5. Chaudhuri L, Vincelette ND, Koh BD, Naylor RM, Flatten KS, Peterson KL, McNally A, Gojo I, Karp JE, Mesa RA, Sproat LO, Bogenberger JM, Kaufmann SH, Tibes R (2013). CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. Haematologica, 99(4), 688-96. (Read full article)

    Review

    1. Uber AM, Sutherland SM (2019). Nephrotoxins and nephrotoxic acute kidney injury. [Review]. Pediatr Nephrol, 35(10), 1825-1833. (Read full article)
    2. Uber AM, Sutherland SM (2018). Acute kidney injury in hospitalized children: consequences and outcomes. [Review]. Pediatr Nephrol, 35(2), 213-220. (Read full article)